Fuereder, Thorsten http://orcid.org/0000-0001-5356-6452
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 7 October 2023
Accepted: 31 October 2023
First Online: 5 December 2023
Conflict of interest
: T. Fuereder is member of advisory boards and/or received honoraria from MSD, MERCK, Roche, Novartis, Amgen, Pfizer, BMS and Boehringer Ingelheim, Takeda and Janssen, Invios, Eli Lilly.